. . . . . . . . "Ketamine has emerged as a rapid-acting antidepressant, though controversy remains whether sufficient data exist to justify its use outside of research protocols. In October 2014, the authors' institution began providing ketamine as an off-label therapy on a case-by-case basis for patients unable to participate in research protocols." . . . . . . "adults" . . . "2021-08-25T15:26:59.279224"^^ . "RSA" . "MIGfMA0GCSqGSIb3DQEBAQUAA4GNADCBiQKBgQCamPJb4SzqpLXn//XJ5dlVfzz6QI+RPmiJTLXF/by2JR7sHMKRsCQDFsYMlq8zGHghOIkjRP9dpLZUtZzUcHt3MXiFKEPo8eGzUe9p+JXKFC8xxkJr94z2vq6IdMf71Iu1GH8SeDAKt/DgYO4zNaw8VuXvxnZRewKZSA+u8zWPVwIDAQAB" . "NsRRDMKuNSqCDLKR8xY/Z6Fk2wBhCKj+fGkxqouPkQc9Fl0baKxitDw2iDun10ARq4fV5l0tleXKJG1CBSCmJLVjij50mVyQRC6R3YyEHbNer72mHS6cOrxIo8wdpQuXfwdZfUg5KtvO54b4zmhcr3EW/b8NV/RnIJCzRVYwuMI=" . . "2021-08-25T15:26:59.279224"^^ . . .